NASDAQ · Biotechnology

Exelixis, Inc. (EXEL) Stock

$62.23 -0.95% NASDAQ: EXEL Healthcare

Valuation

MetricValue
Price$62.23
Market Cap$15.64B
P/E Ratio17.78
P/B Ratio7.96
P/S Ratio6.04
EPS (TTM)$2.78
52-Week High$62.96
52-Week Low$33.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE42.49%
ROA34.50%
ROCE45.56%
Gross Margin96.44%
Operating Margin39.43%
Net Margin35.33%
Debt/Equity0.09
Current Ratio3.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.4B$1.6B$1.8B$2.2B$2.3B
Operating Profit$287.0M$201.0M$171.0M$605.0M$872.0M
Net Profit$231.0M$182.0M$208.0M$521.0M$783.0M
EPS$0.72$0.56$0.65$1.76$2.78
Op Margin20.0%12.5%9.3%27.9%37.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.6B$3.1B$2.9B$2.9B$2.8B
Total Liabilities$406.0M$583.0M$678.0M$703.0M$683.0M
Cash$647.0M$501.0M$263.0M$217.0M$482.0M
Borrowings$51.0M$190.0M$190.0M$191.0M$173.0M

Latest News

EXEL: Lowering target price to $61.00 Argus Research · Jul 15, 2026 Is Exelixis (EXEL) Expensive After Its Recent Rally Or Still Undervalued? Simply Wall St. · Jul 11, 2026 Exelixis (EXEL) Stock Trades At A Discount After Its 236% Run Simply Wall St. · Jul 11, 2026 3 Under-the-Radar Stocks to Buy and Hold Motley Fool · Jul 10, 2026 EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth? Zacks · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$401.0M$363.0M$333.0M$700.0M$884.0M
Investing Cash Flow$-107.0M$-663.0M$-190.0M$-183.0M$311.0M
Financing Cash Flow$-15.0M$-23.0M$-579.0M$-691.0M$-1.0B
Net Cash Flow$343.0M$-161.0M$-240.0M$-46.0M$265.0M
Free Cash Flow$337.0M$224.0M$170.0M$634.0M$844.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.33
EV / EBITDA14.03
FCF Yield7.88%
Quick Ratio3.38
Interest Coverage—
Return 1Y58.71%
Return 3Y185.72%
Return 5Y178.88%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALPMYAstellas Pharma Inc. $13.13 -0.68% 13.19 $23.52B 3.12%
AZNAstraZeneca PLC $165.41 -0.76% 24.77 $256.53B 1.27%
CRISCuris, Inc. $0.41 -19.86% -0.06 $793845 0.00%
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
HCMHUTCHMED (China) Limited $11.25 +0.99% 4.28 $1.96B 0.00%

About Exelixis, Inc.

Exelixis, Inc. is led by CEO Michael Morrissey, employs 1,077 people, headquartered in Alameda, US, publicly traded since 2000.

Exelixis, Inc. (EXEL) stock trades at $62.23 with a market capitalization of $15.64B. The stock is valued at a price-to-earnings (P/E) ratio of 17.78, price-to-book of 7.96, price-to-sales of 6.04. Over the past 52 weeks the stock has ranged between $33.76 and $62.96, and currently trades 1.2% below its 52-week high.

On profitability, Exelixis, Inc. generates a return on equity (ROE) of 42.49%, above the typical market range of roughly 12-15%, return on capital employed of 45.56%, an operating margin of 39.43%, a net profit margin of 35.33%.

In its most recent fiscal year, Exelixis, Inc. reported annual revenue of $2.3B, net profit of $783.0M. Over the last 5 fiscal years, revenue grew at an average annual rate of 18.6%, and net profit grew at an average annual rate of 47.5%. Over that span net profit grew faster than revenue, so net margin widened.

The balance sheet shows a debt-to-equity ratio of 0.09 (debt below half of shareholders' equity), a current ratio of 3.55, total assets of $2.8B, $482.0M in cash and equivalents.

EXEL has an average daily trading volume of 2,474,193 shares, a beta of 0.42 (historically less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1257.03 +0.43% JNJ Johnson & Johnson $255.56 +0.90% ABBV AbbVie Inc. $285.42 +0.71% UNH UnitedHealth Group Incorporated Common Stock (DE) $401.43 -1.29% MRK Merck & Company, Inc. Common Stock (new) $145.97 +0.53% NVS Novartis AG $150.62 +0.16% AZN AstraZeneca PLC $165.41 -0.76% TMO Thermo Fisher Scientific Inc $690.00 -0.93% AMGN Amgen Inc. $432.49 -0.35% GILD Gilead Sciences, Inc. $156.19 -0.75% ABT Abbott Laboratories $104.88 +0.19% NVO Novo Nordisk A/S $38.83 -0.99%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.